Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and recruitment status now shows 'No longer looking for participants'. The Intervention header was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check10 days agoChange DetectedUpdated the location list by replacing Kharkivs’ka Oblast’ with Kharkiv Oblast and adding the detailed location entry for Kharkiv, Kharkiv Oblast, Ukraine, 61070. Revision updated from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a recent backend/software update behind the scenes.SummaryDifference0.0%

- Check38 days agoChange DetectedThe Taiwan site entry in the locations list was revised from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision label was added, updating from v3.5.2 to v3.5.3. This reflects an updated revision of the document or system metadata.SummaryDifference0.0%

- Check53 days agoChange DetectedUpdated the Chile location text to use “Araucania” / “Temuco, Araucania, Chile” instead of “Región de la Araucanía” variants.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.